Publication | Closed Access

Phase I–II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma

Hematological MalignancyMedicineHigh-dose MelphalanImmunologyHematologyMyeloid NeoplasiaMultiple MyelomaCell BiologyRapid SequenceRadiation OncologyOncologyCell TransplantationCancer ResearchHealth Sciences